Dilated cardiomyopathy and heart failure in children.
This article describes the causes and outcomes of dilated cardiomyopathy in children. Genetic, infectious, metabolic, and acquired causes of dilated cardiomyopathy are discussed. The predictors for better and worse outcomes are reviewed. Guidelines for the use of medical and surgical therapies to treat heart failure in children are summarized.
Hsu
Daphne T
DT
Department of Pediatrics, Albert Einstein College of Medicine, 3415 Bainbrige Avenue, Bronx, NY 10467, USA. dhsu@montefiore.org
Canter
Charles E
CE
D002311:Cardiomyopathy, Dilated / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002648:Child; D017147:Defibrillators, Implantable; D020022:Genetic Predisposition to Disease; D006333:Heart Failure / Q000145:classification / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D016027:Heart Transplantation; D006353:Heart-Assist Devices; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000150:complications; D008943:Mitral Valve / Q000601:surgery; D008944:Mitral Valve Insufficiency / Q000601:surgery; D009205:Myocarditis / Q000150:complications / Q000175:diagnosis; D010138:Pacemaker, Artificial; D010641:Phenotype; D011379:Prognosis
D002316:Cardiotonic Agents